Rani Therapeutics Holdings (RANI) Common Equity (2020 - 2026)
Rani Therapeutics Holdings (RANI) posted Common Equity of $47.99 million for Q2 2026, compared with -$9.15 million a year earlier and up 35.0% from the prior quarter.
Powered by 
Analysis
Rani Therapeutics Holdings (RANI) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Rani Therapeutics Holdings' Common Equity came in at $41.51 million.
- In prior years, Rani Therapeutics Holdings' Common Equity was $3.49 million in FY2024 (-86.3%), $25.44 million in FY2023 (-65.6%), $74 million in FY2022 (-39.1%) and $121.57 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Common Equity since Q2 2023.
- Across the past five years, year-over-year decline in Common Equity ran from 34.2% in Q3 2022 to 88.5% in Q2 2024.
- According to Business Quant data, Common Equity for the three prior quarters was $35.54 million (Q1 2026), $41.51 million (Q4 2025) and -$11.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Rani Therapeutics Holdings | 109.55 Mn | -10.01 Mn | - | 47.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.99 Mn |
| Mar 31, 2026 | 35.54 Mn |
| Dec 31, 2025 | 41.51 Mn |
| Sep 30, 2025 | -11.97 Mn |
| Jun 30, 2025 | -9.15 Mn |
| Mar 31, 2025 | -5.35 Mn |
| Dec 31, 2024 | 3.49 Mn |
| Sep 30, 2024 | 5.78 Mn |
| Jun 30, 2024 | 5.55 Mn |
| Mar 31, 2024 | 14.54 Mn |
| Dec 31, 2023 | 25.44 Mn |
| Sep 30, 2023 | 34.82 Mn |
| Jun 30, 2023 | 48.17 Mn |
| Mar 31, 2023 | 61.59 Mn |
| Dec 31, 2022 | 74.00 Mn |
| Sep 30, 2022 | 86.61 Mn |
| Jun 30, 2022 | 98.65 Mn |
| Mar 31, 2022 | 110.64 Mn |
| Dec 31, 2021 | 121.57 Mn |
| Sep 30, 2021 | 131.71 Mn |
API Access
Rani Therapeutics Holdings Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RANI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RANI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RANI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();